Eduardo B. Martins

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma et al. · Gastroenterology · 2015 · 338 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Naoky Tsai, Joerg Petersen, Robert Flisiak et al. · Digestive Diseases and Sciences · 2014 · 298 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

W. Ray Kim, Thomas Berg, Tarik Asselah et al. · Journal of Hepatology · 2015 · 291 citations

Medicine, Internal Medicine, Pathology +15

Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B

W. Ray Kim, Rohit Loomba, Thomas Berg et al. · Cancer · 2015 · 214 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

Scott A. Halperin, Brian J. Ward, Curtis Cooper et al. · Vaccine · 2012 · 131 citations

Veterinary Medicine, Immunology, Infectious Diseases +13